摩根基金-基因治療主題基金- JPM 基因治療主題(美元) - A股(累計)
101.28美元0.21(0.21%)
2023/03/31更新
暫無投資策略資料
大型 | |||
---|---|---|---|
中型 | |||
小型 | |||
價值型 | 均衡型 | 增長型 |
Yozann Romahi, PhD, CFA, managing director, is CIO for AM Solutions – Quantitative Solutions focused on managing and developing the firm's systematic and factor-based franchise across strategic beta and thematics. He is also responsible for leading the firm's Multi-Asset Quantitative Research capabilities. Prior to joining J.P. Morgan in 2003, Yazann worked as a research analyst at the Centre for Financial Research at the University of Cambridge and undertook consulting assignments for a number of financial institutions including Pioneer Asset Management, PricewaterhouseCoopers and HSBC.
Aijas Hussain,Vice President, is a portfolio analyst in the Quantitative Beta Strategies group, based in London. Prior to joining J.P. Morgan Asset Management in 2016, Aijaz worked as an Analytics Consultant at FactSet Research Systems. Aijaz graduated from Imperial College London with a BSc in Mathematics.